You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma, Basal Cell

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity, Healthy Lifestyle Trial (other, drug, procedure)

Not yet recruiting
  • Obesity
  • Healthy Lifestyle
  • Lifestyle Intervention
  • +4 more
  • (no location specified)
Dec 7, 2022

Immune Alterations in Operable Breast and Ovarian Carcinoma

Not yet recruiting
  • Ovarian Carcinoma
  • Breast Carcinoma
    • Lyon, France
      Centre Léon Bérard
    Sep 24, 2020

    Its Main Risk Factors Among Egyptian

    Recruiting
    • NAFLD
    • +2 more
      • Cairo, Egypt
        Faculty of Medicine Cairo University
      Mar 9, 2022

      Bladder Cancer Recurrent, Non-Invasive Bladder Urothelial Carcinoma Trial in Ankara, Istanbul, Izmir

      Recruiting
      • Bladder Cancer Recurrent
      • Non-Invasive Bladder Urothelial Carcinoma
        • Ankara, Turkey
        • +2 more
        Apr 10, 2022

        Ovarian Cancer Trial (Autologous genetically modified ADP-A2M4CD8 cells, Autologous genetically modified ADP-A2M4CD8 cells in

        Not yet recruiting
        • Ovarian Cancer
        • Autologous genetically modified ADP-A2M4CD8 cells
        • Autologous genetically modified ADP-A2M4CD8 cells in combination with Nivolumab
        • (no location specified)
        Jan 31, 2023

        Hepatocellular Carcinoma Trial in Guangzhou (Hepatic arterial infusion chemo, Lenvatinib, Toripalimab)

        Unknown status
        • Hepatocellular Carcinoma
        • Hepatic arterial infusion chemotherapy
        • +2 more
        • Guangzhou, Guangdong, China
          Cancer Center Sun Yat-sen University
        Sep 22, 2020

        Advanced, Metastatic Breast Cancer Trial in Worldwide (LEE011, Letrozole, LEE011 Placebo)

        Active, not recruiting
        Has Results
        • Advanced, Metastatic Breast Cancer
        • Chandler, Arizona
        • +222 more
        Dec 3, 2021

        Lymphoma, Mantle-Cell Trial in Worldwide (Ibrutinib, Lenalidomide, Rituximab)

        Recruiting
        • Lymphoma, Mantle-Cell
        • Barretos, Brazil
        • +150 more
        Jan 27, 2023

        Liver Cancer Trial in Zhuhai (No intervention)

        Recruiting
        • Liver Cancer
        • No intervention
        • Zhuhai, Guangdong, China
          Zhuhai People's Hospital
        May 14, 2023

        Follicular Lymphoma, Indolent B-Cell Non-Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Seattle (Laboratory Biomarker

        Active, not recruiting
        Has Results
        • Follicular Lymphoma
        • +2 more
        • Laboratory Biomarker Analysis
        • Pembrolizumab
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Dec 6, 2022

        ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

        Recruiting
        • ARID1A Gene Mutation
        • +15 more
        • Scottsdale, Arizona
        • +4 more
        Dec 13, 2022

        Kidney Failure Trial in Chicago, Durham (Enriched Hematopoietic Stem Cell Infusion)

        Active, not recruiting
        • Kidney Failure
        • Enriched Hematopoietic Stem Cell Infusion
        • Chicago, Illinois
        • +1 more
        Jul 15, 2022

        NSCLC Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Bevacizumab, Carboplatin)

        Completed
        Has Results
        • Carcinoma, Non-Small-Cell Lung
        • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
        • +3 more
        • Chandler, Arizona
        • +239 more
        Aug 26, 2021

        Analyzing Urine During BCG Instillation in Bladder Cancer

        Not yet recruiting
        • Bladder Cancer
        • urine sample collection
        • Shanghai, Shanghai, China
          Changhai Hospital
        Nov 30, 2023

        CNS Lymphoma Trial in Nanchang (Human CD19-CD22 Targeted T Cells Injection)

        Recruiting
        • Central Nervous System Lymphoma
        • Human CD19-CD22 Targeted T Cells Injection
        • Nanchang, Jiangxi, China
          The Second Affiliated Hospital of Nanchang University
        Dec 13, 2022

        Chronic Kidney Diseases, Hypertension, Aging Trial in Aurora (IMST, Sham Training)

        Recruiting
        • Chronic Kidney Diseases
        • +3 more
        • IMST
        • Sham Training
        • Aurora, Colorado
          University of Colorado - Anschutz Medical Campus
        Apr 21, 2022

        Delirium in Children Undergoing Stem Cell Transplantation

        Recruiting
        • Stem Cell Transplant Complications
        • Delirium
        • Daily screening for delirium
        • San Francisco, California
        • +5 more
        Sep 13, 2022

        B-Cell Lymphoma, B Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Pittsburgh (Chimeric Antigen Receptor

        Recruiting
        • B-Cell Lymphoma
        • +8 more
        • Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
        • Pittsburgh, Pennsylvania
          AHN Cancer Institute - West Penn Hospital
        Aug 10, 2022

        PDAC - Pancreatic Ductal Adenocarcinoma, FAP Trial in New York ([68Ga]FAPI-46)

        Recruiting
        • PDAC - Pancreatic Ductal Adenocarcinoma
        • FAP
        • New York, New York
          NYU Langone Health
        May 3, 2022

        Locally Advanced Nasopharyngeal Carcinoma Trial in Seoul (Nivolumab)

        Not yet recruiting
        • Locally Advanced Nasopharyngeal Carcinoma
        • Seoul, Korea, Republic of
          Yonsei University Health System, Severance Hospital
        May 26, 2021

        Hepatocellular Carcinoma, Hepatitis C, Tumor Recurrence Trial in Alexandria (Velpatasvir/Sofosbuvir)

        Active, not recruiting
        • Hepatocellular Carcinoma
        • +3 more
        • Alexandria, Egypt
          Alexandria University, Faculty of Medicine
        Jan 14, 2022

        Lung Diseases, Tumors, Respiratory Tract Diseases Trial in Chengdu (Apatinib, SHR-1210)

        Unknown status
        • Lung Diseases
        • +4 more
        • Chengdu, Sichuan, China
          Sichuan Cancer Hospital
        Oct 17, 2019

        B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma Trial in Aurora (CD19CAR-CD3Zeta-4-1BB-Expressing Autologous

        Recruiting
        • B-cell Acute Lymphoblastic Leukemia
        • B-cell Non Hodgkin Lymphoma
        • CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
        • Aurora, Colorado
          Children's Hospital Colorado
        Nov 9, 2022

        Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Arising

        Not yet recruiting
        • Acute Myeloid Leukemia
        • +4 more
        • (no location specified)
        Nov 8, 2022

        COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in

        Not yet recruiting
        • Follicular Lymphoma
        • Cellular immunity vs SARS-CoV-2
        • +6 more
        • Alessandria, IT, Italy
        • +13 more
        Oct 10, 2023